True, they are after bagger return of 15-20c in the ST due to VAXINIA and especially OASIS which is why they had to pay a premium for the $46M CN and warrant. It's risk free for them as they can request IMU to buy back at 10% if these clinical trial updates aren't further positive. Can they not convert more than $2M in 6 months period???? If that's the case, it will work even better for traders and ST to buy the shares if they push the pps lower as they won't be able to dump as much on release of the clinical trial updates.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)